Concepedia

Chaitali Dutta

CD

16

Publications

1.6K

Citations

14

H-Index

1998

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

University of Massachusetts Chan Medical School

Harvard University

Dicerna Pharmaceuticals (United States)

Verve Therapeutics (United States)

Chaitali Dutta is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and molecular biology.

Top concepts

MedicineCell BiologyCell CycleMolecular BiologyTranscriptional RegulationGeneticsCell DeathEngineeringDna ReplicationGene Expression

Publications per year

1998–2023

16

Publications

16

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

Kiran Musunuru, Alexandra C. Chadwick, Taiji Mizoguchi et al. · Nature · 2021 · 713 citations

Knockout Mouse, Genetics, Genetic Engineering +8

p53 regulates a non-apoptotic death induced by ROS

Joan Montero, Chaitali Dutta, Diederik van Bodegom et al. · Cell Death and Differentiation · 2013 · 137 citations · Full text

Non-apoptotic Death, Apoptosis, Cell Death +4

GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy

Lisa N. Kasiewicz, Souvik Biswas, Aaron Beach et al. · Nature Communications · 2023 · 117 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +18

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

Cheng-Jung Lai, Natalie W. Pursell, Jessica J. Gierut et al. · Molecular Therapy · 2018 · 104 citations · Full text

The Microphthalmia-associated Transcription Factor Requires SWI/SNF Enzymes to Activate Melanocyte-specific Genes

Ivana L. de la Serna, Yasuyuki Ohkawa, Chiduru Higashi et al. · Journal of Biological Chemistry · 2006 · 98 citations · Full text

Transcriptional Regulation, Systems Biology, Developmental Biology +15

Rows per page

1–5 of 16